Mesa Laboratories (MLAB) CFO reports grants, RSU conversions and tax-cover share sale
Rhea-AI Filing Summary
Mesa Laboratories CFO John Sakys reported multiple equity transactions in Mesa Laboratories common stock. On June 18, 2026, he received a grant of 2,282 shares of common stock and exercised restricted stock units (RSUs) that converted into 2,756 and 1,036 shares of common stock.
On June 22, 2026, he sold 2,827 shares at an average price of $89.502 per share. A footnote states these shares were sold to cover taxes related to the vesting of RSUs and performance share units on June 18, 2026, and that the transaction was executed under a Rule 10b5-1 trading plan.
After these transactions, Sakys held 19,785 Mesa Laboratories shares directly, plus 50 shares indirectly as custodian for his children.
Positive
- None.
Negative
- None.
Insider Trade Summary
Exercise and sale activity reported; no spread calculated
Exercise and Sale
7 txns
Insider
Sakys John
Role
CFO
Sold
2,827 shs ($253K)
Approx. gross sale proceeds
$253K
Approx. exercise cost
$0.00
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 2,827 | $89.502 | $253K |
| Exercise | Restricted Stock Units - 6 | 1,036 | $0.00 | $0.00 |
| Exercise | Restricted Stock Units - 7 | 2,756 | $0.00 | $0.00 |
| Exercise | Common Stock | 1,036 | $95.10 | $99K |
| Exercise | Common Stock | 2,756 | $95.10 | $262K |
| Grant/Award | Common Stock | 2,282 | $95.10 | $217K |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Restricted Stock Units - 6 — 0 shares (Direct);
Restricted Stock Units - 7 — 2,755 shares (Direct);
Common Stock — 19,785 shares (Direct);
Common Stock — 50 shares (Indirect, Custodian)
Footnotes (7)
- F1. Each RSU represents a contingent right to receive one share of the Issuer's common stock.
- F2. RSUs that vested June 21, 2024 and each of the next two anniversary dates
- F3. Not Applicable
- F4. RSUs that vest 1/3 on June 15, 2026 and each of the next 2 anniversary dates
- F5. Shares represent common stock of Mesa Labs issued upon release of performance share units issued under the FY24-FY26 performance share unit program
- F6. Shares sold to cover taxes related to the vesting of RSUs and PSUs on June 18, 2026. Transaction was executed under a 10b5-1 plan.
- F7. Consists of 50 shares held by children of which Mr. Sakys is custodian
Key Figures
Shares sold: 2,827 shares
Sale price: $89.502/share
Direct holdings after sale: 19,785 shares
+5 more
8 metrics
Shares sold
2,827 shares
Open-market sale on June 22, 2026 at $89.502 per share
Sale price
$89.502/share
Average price for 2,827 shares sold on June 22, 2026
Direct holdings after sale
19,785 shares
Common stock directly owned by CFO after reported transactions
Indirect custodian holdings
50 shares
Shares held for children where CFO is custodian
Equity grant
2,282 shares
Common stock grant/award on June 18, 2026 at $95.10
RSU conversion 1
2,756 shares
Common shares issued from Restricted Stock Units - 7 on June 18, 2026
RSU conversion 2
1,036 shares
Common shares issued from Restricted Stock Units - 6 on June 18, 2026
RSU exercise price
$0.00/share
Conversion or exercise price for RSU-derived shares
Key Terms
Restricted Stock Units, performance share units, Rule 10b5-1 plan, custodian, +2 more
6 terms
Restricted Stock Units financial
"Each RSU represents a contingent right to receive one share of the Issuer's common stock."
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
Rule 10b5-1 plan regulatory
"Transaction was executed under a 10b5-1 plan."
A Rule 10b5-1 plan is a prearranged, written schedule that lets corporate insiders buy or sell company stock at set times or amounts, even if they later learn material nonpublic information. Think of it like setting an automatic thermostat for trades: it creates a clear record that trades were planned in advance, reducing the risk of insider-trading accusations and helping investors trust that insider transactions are routine rather than based on secret information.
custodian financial
"Consists of 50 shares held by children of which Mr. Sakys is custodian"
A custodian is a financial institution that holds and safeguards an investor's assets—such as stocks, bonds, or cash—and records transactions on the investor's behalf. Think of it as a trusted caretaker or safe-deposit box for investments; it helps prevent loss or theft, handles paperwork and transfers, and provides transparency and regulatory checks, so investors can focus on decisions rather than the mechanics or security of asset storage.
grant, award, or other acquisition financial
"Grant, award, or other acquisition"
Exercise or conversion of derivative security financial
"Exercise or conversion of derivative security"
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What insider transactions did Mesa Laboratories (MLAB) CFO John Sakys report?
John Sakys reported a mix of equity transactions. He received 2,282 common shares as a grant, exercised RSUs converting into 3,792 common shares, and then sold 2,827 shares. These moves reflect routine equity compensation and related tax-management activity.
What is a Rule 10b5-1 plan in the context of Mesa Laboratories (MLAB) CFO’s trades?
A Rule 10b5-1 plan is a pre-arranged trading program. The filing notes the CFO’s tax-cover sale on June 22, 2026 was executed under such a plan, indicating trades were scheduled in advance rather than timed based on nonpublic information or short-term market conditions.
What RSU and PSU activity did Mesa Laboratories (MLAB) disclose for its CFO?
The CFO’s RSUs converted into common stock on June 18, 2026. The filing shows 2,756 and 1,036 RSU-related shares issued, plus 2,282 shares from a grant. A footnote adds that some shares came from performance share units under the FY24–FY26 program.